Skip to content

Clinical trials

Cardiomyopathy, Dilated trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathy, Dilated Clear all

242 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20021
20034
20045
20055
20066
200714
200811
20097
20106
201112
20126
20139
201416
20156
201612
20177
201814
201916
202017
20218
202210
20238
202412
202511
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed97
Unknown status56
Recruiting43
Terminated18
Active, not recruiting10
Withdrawn7
Not yet recruiting5
Suspended3
Enrolling by invitation3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Imperial College London9
University Medical Centre Ljubljana6
LoneStar Heart, Inc.4
Ancora Heart, Inc.3
AstraZeneca3
French Cardiology Society3
Göteborg University3
Hospital General Universitario Gregorio Marañon3
Institut National de la Santé Et de la Recherche Médicale, France3
Johns Hopkins University3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathy, Dilated242
Heart Failure91
Cardiomyopathy, Hypertrophic38
Cardiomyopathies35
Cardiomyopathy, Restrictive14
Arrhythmogenic Right Ventricular Dysplasia13
Death, Sudden, Cardiac13
Heart Diseases12
Cardiovascular Diseases11
Myocarditis9

Trials

Showing 1 to 25 of 242. Each trial links to its page on Pharma Observatory.

142 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.